Skip to main content Start of content

HESA Committee Meeting

Notices of Meeting include information about the subject matter to be examined by the committee and date, time and place of the meeting, as well as a list of any witnesses scheduled to appear. The Evidence is the edited and revised transcript of what is said before a committee. The Minutes of Proceedings are the official record of the business conducted by the committee at a sitting.

For an advanced search, use Publication Search tool.

If you have any questions or comments regarding the accessibility of this publication, please contact us at

Previous day publication Next day publication

Notice of meeting Amended

Standing Committee on Health (HESA)
43rd Parliament, 1st Session
Meeting 31
Monday, July 6, 2020, 11:00 a.m. to 2:00 p.m.

11:00 a.m. to 12:30 p.m.
Amended Section
Canadian Center for Vaccinology
• Dr. Scott Halperin, Director of Microbiology and Immunolgy, Professor of Pediatrics, Dalhousie University
Canadian Generic Pharmaceutical Association
• Jim Keon, President
• Peter Hardwick, Chief Commercial Officer and Executive Vice-President, ApotexAmended
Innovative Medicines Canada
• Pamela Fralick, President
• Dion Neame, Country Medical Lead, Sanofi Canada

12:30 p.m. to 2:00 p.m.
As an individual
• Mario Possamai, Senior Advisor, Commission to Investigate the Introduction and Spread of Severe Acute Respiratory Syndrome (SARS), 2003-2007
• Paramvir Nagpal, Founder and Chief Executive Officer
Medtronic Canada
• Patrick Hupé, Senior Director, Health System Strategies
Committee Clerk
Erica Pereira (613-995-4108)
2020-06-29 8:55 a.m.